Turn this role into an interview — a resume and cover letter built around what this employer wants.
Lonza is seeking an ELN Implementation specialist to join its Biologics R&D team in Slough. You will own and deliver lab informatics solutions (ELN, SDMS) enabling scalable, high-quality workflows across R&D.
You will lead end-to-end implementation, drive adoption, and partner with scientists to translate workflows into structured digital solutions. Strong data modelling, FAIR principles, and API integrations are essential.
Slough, UK
The actual location of this job is in Slough, United Kingdom. Join Lonza’s Biologics R&D team and play a pivotal role in shaping the digital future of laboratory science. This role sits at the intersection of science, data, and engineering, with a strong focus on owning and delivering laboratory informatics solutions (ELN, SDMS) that enable scalable, high-quality scientific workflows. This is a unique opportunity to take ownership of lab informatics systems and play a key role in Lonza’s digital transformation. You will work in a highly collaborative environment, bridging science and technology to enable next-generation R&D.
What you will get:
The full list of our global benefits can be found here:
https://www.lonza.com/careers/benefits
What you will do:
What we are looking for:
About Lonza
At Lonza, our people are our greatest strength. With 30+ sites across five continents, our globally connected teams work together every day to manufacture the medicines of tomorrow. Our core values of Collaboration, Accountability, Excellence, Passion and Integrity reflect who we are and how we work together. Everyone’s ideas, big or small, have the potential to improve millions of lives, and that’s the kind of work we want you to be part of.
Innovation thrives when people from all backgrounds bring their unique perspectives to the table. At Lonza, we value diversity and are committed to creating an inclusive environment for all employees. If you’re ready to help turn our customers’ breakthrough ideas into viable therapies, we look forward to welcoming you on board.